FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312773444> ?p ?o ?g. }

• W4312773444 endingPage "108" @default.
• W4312773444 startingPage "108" @default.
• W4312773444 abstract "Objective: Androgenetic alopecia (AGA) is a common type of alopecia characterized by the shortening of the anagen phase of hair growth and the miniaturization of hair follicles. TGF-β is a well-known hair cycle catagen phase inducer and is involved in the catagen phase in AGA. Inhibition of TGF-β is recognized as a therapeutic option in the treatment of AGA. Procyanidins are a type of polyphenol that has been shown to inhibit TGF-β activity in vivo, but there haven’t been many studies on their effectiveness. In this study, we aimed to evaluate the efficacy and safety of topical procyanidin B2 in the treatment of male AGA. Materials and Methods: Patients aged between 18 and 50 years who applied to our dermatology outpatient clinic with the complaint of AGA and had Hamilton-Norwood type II-V AGA were included in our study. Those who had received 5-reductase inhibitor or isotretinoin treatment in the previous year, those who had used any medicinal or herbal product that stimulated hair growth, particularly topical minoxidil, in the previous six months, those who had used systemic steroids for more than two weeks in the previous three months, those who had undergone a transplant or scalp reduction, and those who had received radiotherapy or chemotherapy at any point in their lives were excluded from the study. A total of 40 patients who met the current criteria were included in the study. Patients were randomized into two groups to receive 16 weeks of topical procyanidin B2 (n = 20) or placebo (n = 20) therapy. At the end of the treatment, the patients were called for control. The efficacy of topical procyanidin B2 after treatment was evaluated by trichoscan and global photographic evaluation. Results: A total of 40 male patients (mean: 33.32, range: 21–44) with AGA type II-IV were included in the study. There was no significant difference between the two groups in terms of age, duration of hair loss, and AGA type (P > 0.05). At the end of the study, there was a significant increase in total hair count in the topical procyanidin B2 group compared to the placebo group compared to baseline (P < 0.05). Anagen hair count was also significantly increased in the topical procyanidin B2 group (P < 0.05). Conclusion: In this placebo-controlled study, we think that topical procyanidin B2 is an effective and safe treatment option in the treatment of AGA patients." @default.
• W4312773444 created "2023-01-05" @default.
• W4312773444 creator A5011868936 @default.
• W4312773444 creator A5048831110 @default.
• W4312773444 date "2022-01-01" @default.
• W4312773444 modified "2023-09-30" @default.
• W4312773444 title "Evaluation of the efficacy and safety of topical procyanidin b2 and placebo in the treatment of androgenetic alopecia in men; A randomized, double-blind, placebo-controlled study" @default.
• W4312773444 cites W1586532382 @default.
• W4312773444 cites W1956979632 @default.
• W4312773444 cites W1969051501 @default.
• W4312773444 cites W1973056519 @default.
• W4312773444 cites W1986744290 @default.
• W4312773444 cites W2002865604 @default.
• W4312773444 cites W2008313637 @default.
• W4312773444 cites W2056943916 @default.
• W4312773444 cites W2058252432 @default.
• W4312773444 cites W2066872156 @default.
• W4312773444 cites W2074536439 @default.
• W4312773444 cites W2078774668 @default.
• W4312773444 cites W2080055212 @default.
• W4312773444 cites W2093342637 @default.
• W4312773444 cites W2096481079 @default.
• W4312773444 cites W2097823157 @default.
• W4312773444 cites W2104656503 @default.
• W4312773444 cites W2113685442 @default.
• W4312773444 cites W2127205346 @default.
• W4312773444 cites W2144744212 @default.
• W4312773444 cites W2145359554 @default.
• W4312773444 cites W2170896829 @default.
• W4312773444 cites W2171842245 @default.
• W4312773444 cites W2237162329 @default.
• W4312773444 cites W2800434618 @default.
• W4312773444 cites W2909165413 @default.
• W4312773444 cites W2914595326 @default.
• W4312773444 cites W3014753407 @default.
• W4312773444 cites W3210217088 @default.
• W4312773444 cites W4230438426 @default.
• W4312773444 cites W4243433496 @default.
• W4312773444 doi "https://doi.org/10.4103/tjd.tjd_41_22" @default.
• W4312773444 hasPublicationYear "2022" @default.
• W4312773444 type Work @default.
• W4312773444 citedByCount "0" @default.
• W4312773444 crossrefType "journal-article" @default.
• W4312773444 hasAuthorship W4312773444A5011868936 @default.
• W4312773444 hasAuthorship W4312773444A5048831110 @default.
• W4312773444 hasBestOaLocation W43127734441 @default.
• W4312773444 hasConcept C126322002 @default.
• W4312773444 hasConcept C142724271 @default.
• W4312773444 hasConcept C16005928 @default.
• W4312773444 hasConcept C168563851 @default.
• W4312773444 hasConcept C197934379 @default.
• W4312773444 hasConcept C203092338 @default.
• W4312773444 hasConcept C204787440 @default.
• W4312773444 hasConcept C27081682 @default.
• W4312773444 hasConcept C2776285725 @default.
• W4312773444 hasConcept C2776360568 @default.
• W4312773444 hasConcept C2777673923 @default.
• W4312773444 hasConcept C2778515351 @default.
• W4312773444 hasConcept C2779711729 @default.
• W4312773444 hasConcept C71924100 @default.
• W4312773444 hasConcept C98274493 @default.
• W4312773444 hasConceptScore W4312773444C126322002 @default.
• W4312773444 hasConceptScore W4312773444C142724271 @default.
• W4312773444 hasConceptScore W4312773444C16005928 @default.
• W4312773444 hasConceptScore W4312773444C168563851 @default.
• W4312773444 hasConceptScore W4312773444C197934379 @default.
• W4312773444 hasConceptScore W4312773444C203092338 @default.
• W4312773444 hasConceptScore W4312773444C204787440 @default.
• W4312773444 hasConceptScore W4312773444C27081682 @default.
• W4312773444 hasConceptScore W4312773444C2776285725 @default.
• W4312773444 hasConceptScore W4312773444C2776360568 @default.
• W4312773444 hasConceptScore W4312773444C2777673923 @default.
• W4312773444 hasConceptScore W4312773444C2778515351 @default.
• W4312773444 hasConceptScore W4312773444C2779711729 @default.
• W4312773444 hasConceptScore W4312773444C71924100 @default.
• W4312773444 hasConceptScore W4312773444C98274493 @default.
• W4312773444 hasIssue "4" @default.
• W4312773444 hasLocation W43127734441 @default.
• W4312773444 hasOpenAccess W4312773444 @default.
• W4312773444 hasPrimaryLocation W43127734441 @default.
• W4312773444 hasRelatedWork W2081731315 @default.
• W4312773444 hasRelatedWork W2109794961 @default.
• W4312773444 hasRelatedWork W2234732310 @default.
• W4312773444 hasRelatedWork W2242770840 @default.
• W4312773444 hasRelatedWork W2408351751 @default.
• W4312773444 hasRelatedWork W2810081498 @default.
• W4312773444 hasRelatedWork W3130549306 @default.
• W4312773444 hasRelatedWork W4235694801 @default.
• W4312773444 hasRelatedWork W4293393600 @default.
• W4312773444 hasRelatedWork W2185654466 @default.
• W4312773444 hasVolume "16" @default.
• W4312773444 isParatext "false" @default.
• W4312773444 isRetracted "false" @default.
• W4312773444 workType "article" @default.